Molecular biology of human immunodeficiency virus type 1 - PubMed

Affiliations

• PMID: 11045374

Review

Molecular biology of human immunodeficiency virus type 1

W K Wang et al. J Microbiol Immunol Infect. 2000 Sep.

Abstract

Since the discovery of human immunodeficiency virus (HIV) as the etiologic agent of acquired immune deficiency syndrome (AIDS) more than a decade ago, tremendous progress has been made in various aspects of this virus and its interplay with the host immune system. The advent of potent combination therapy has made it possible to achieve effective and durable control of HIV-1 replication in vivo, yet the persistence of the latent reservoirs pose a new challenge. The recent identifications of several cellular proteins interacting with different viral gene products have not only shed new insights into our understanding of the HIV-1 and the host cell biology, but also provided the bases for developing novel strategies to block HIV-1 replication. It is from this perspective that we review the current understanding of the molecular mechanisms governing the HIV-1 life cycle.

Similar articles

• Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

  Liu J, Woffendin C, Yang ZY, Nabel GJ. Liu J, et al. Gene Ther. 1994 Jan;1(1):32-7. Gene Ther. 1994. PMID: 7584057

• Biology of HIV-1 and treatment strategies.

  Terwilliger EF. Terwilliger EF. Emerg Med Clin North Am. 1995 Feb;13(1):27-42. Emerg Med Clin North Am. 1995. PMID: 7851319 Review.

• Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.

  Quivy V, De Walque S, Van Lint C. Quivy V, et al. Subcell Biochem. 2007;41:371-96. Subcell Biochem. 2007. PMID: 17484137 Review.

• Viral and host cofactors facilitate HIV-1 replication in macrophages.

  Wahl SM, Greenwell-Wild T, Peng G, Ma G, Orenstein JM, Vazquez N. Wahl SM, et al. J Leukoc Biol. 2003 Nov;74(5):726-35. doi: 10.1189/jlb.0503220. Epub 2003 Jul 22. J Leukoc Biol. 2003. PMID: 12960226 Review.

• [Pathogenesis of human immunodeficiency virus infection].

  Reyes-Terán G, Alcocer Varela J. Reyes-Terán G, et al. Rev Invest Clin. 1994 Mar-Apr;46(2):113-47. Rev Invest Clin. 1994. PMID: 8052741 Review. Spanish.

Cited by

• Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.

  Garcia-Miranda P, Becker JT, Benner BE, Blume A, Sherer NM, Butcher SE. Garcia-Miranda P, et al. J Virol. 2016 Jul 11;90(15):6906-6917. doi: 10.1128/JVI.00149-16. Print 2016 Aug 1. J Virol. 2016. PMID: 27194769 Free PMC article.

• Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?

  Kandathil AJ, Kannangai R, Abraham OC, Pulimood SA, Sridharan G. Kandathil AJ, et al. Bioinformation. 2009 Dec 12;4(6):237-41. doi: 10.6026/97320630004237. Bioinformation. 2009. PMID: 20975916 Free PMC article.

• Cleavage, a real turn-off? HIV-mediated proteolysis of PABP1.

  Collier B, Gray NK. Collier B, et al. Biochem J. 2006 Jun 1;396(2):e9-11. doi: 10.1042/bj20060545. Biochem J. 2006. PMID: 16703665 Free PMC article.

• Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.

  McGettigan JP, Naper K, Orenstein J, Koser M, McKenna PM, Schnell MJ. McGettigan JP, et al. J Virol. 2003 Oct;77(20):10889-99. doi: 10.1128/jvi.77.20.10889-10899.2003. J Virol. 2003. PMID: 14512539 Free PMC article.

• The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env.

  Sivaraman V, Zhang L, Meissner EG, Jeffrey JL, Su L. Sivaraman V, et al. J Virol. 2009 Nov;83(22):11715-25. doi: 10.1128/JVI.00649-09. Epub 2009 Sep 2. J Virol. 2009. PMID: 19726524 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database